CD40LG Triplication Associates with Immune Dysregulation and Exhaustion

J Clin Immunol. 2023 Feb;43(2):323-326. doi: 10.1007/s10875-022-01392-5. Epub 2022 Nov 8.

Authors

Wenny Santaniemi¹, Nora Pernaa¹, Virpi Glumoff¹, Timo Hautala^{2

3}; CD40L consortium

Collaborators

CD40L consortium:
Pirjo Åström, Outi Kuismin

Affiliations

¹ Research Unit of Biomedicine, University of Oulu, FIN-90014, Oulu, Finland.
² Research Unit of Biomedicine, University of Oulu, FIN-90014, Oulu, Finland. timo.hautala@oulu.fi.
³ Infectious Diseases Clinic, Oulu University Hospital, Oulu, Finland. timo.hautala@oulu.fi.

PMID: 36346498
DOI: 10.1007/s10875-022-01392-5

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

CD40 Ligand*
Humans

Substances

CD40 Ligand